Aclaris Therapeutics Inc (ACRS)
1.21
-0.15
(-11.03%)
USD |
NASDAQ |
May 08, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 10.73M |
| March 31, 2021 | 10.69M |
| December 31, 2020 | 10.65M |
| Date | Value |
|---|---|
| September 30, 2020 | 10.61M |
| June 30, 2020 | 10.57M |
| March 31, 2020 | 10.57M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 29.93M |
| June 30, 2019 | 29.92M |
| March 31, 2019 | 29.92M |
| December 31, 2018 | 29.91M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
29.93M
Maximum
Sep 2019
6.510M
Average
--
Median
Dec 2019
Total Long Term Debt (Quarterly) Benchmarks
| Aldeyra Therapeutics Inc | -- |
| Akoya Biosciences Inc | 75.25M |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.138M |